PYC Therapeutics | WA Innovation Ecosystem Navigator
About PYC Therapeutics
PYC Therapeutics is a clinical-stage biotech company focused on developing a new generation of RNA therapeutics aimed at treating genetic diseases with limited or no existing treatment options. Utilizing proprietary RNA drug delivery technology, PYC develops therapies for diseases of the eye, central nervous system, and kidney, with a strategic focus on monogenic and haploinsufficiency disorders. The company combines scientific innovation, clinical insight, and advanced delivery platforms to deliver life-changing treatments for inherited diseases.
Ecosystem activity
2021
1 milestone
November
Received $96K grant from
New Industries and Innovation Fund
Is this your organisation?
Claim this profile to add your story, team and milestones.